Segments - by Product Type (Vacuum Tubes, Micro-Collection Tubes, Serum Separator Tubes, Plasma Separation Tubes, Others), by Material (Plastic, Glass, Others), by End-user (Hospitals, Diagnostic Laboratories, Blood Banks, Others)
The single-use containers for human venous blood specimen collection market size was USD 1.3 Billion in 2023 and is projected to reach USD 2.7 Billion by 2032, expanding at a CAGR of 8.3% during 2024–2032.
Their small size and efficiency not only make them ideal for tests requiring minimal blood but also reduce biological waste, aligning with the increasing environmental sustainability policies in healthcare facilities. As healthcare providers continue to prioritize patient comfort and safety, the segment is expected to grow at a significant growth rate in the coming years.
Despite the higher cost and fragility of glass compared to plastics, its demand remains robust in specialized medical testing and research applications where sample integrity is paramount. The ongoing development of tougher, more resilient types of glass continues to mitigate concerns over breakage, fueling the growth of the segment.
The increasing prevalence of chronic diseases worldwide, which necessitates frequent monitoring and testing. For instance,
According to the United Nations, chronic diseases such as cardiovascular diseases, cancer, diabetes and respiratory illnesses are projected to account for 86% of the 90 million deaths each year by 2050.
Conditions such as diabetes, cardiovascular diseases, and renal disorders require regular blood tests to manage and monitor patient health effectively. This ongoing need for diagnostics is a significant driver for the demand for blood collection products. Additionally, the global rise in healthcare awareness and preventive care measures has led to an increase in routine blood testing, further propelling market growth.
Technological advancements in medical practices and diagnostics also play a crucial role, as newer, more sophisticated testing methods often require specific types of blood collection containers. The growing emphasis on hygiene and safety in medical procedures to prevent cross-contamination and infections has led to a preference for single-use, disposable containers, which ensure a higher standard of cleanliness and patient safety.
The stringent regulatory requirements for the approval of medical devices, including blood collection containers hinders the market. These regulations can vary widely by region, complicating the process for manufacturers to launch their products globally.
The cost associated with meeting these regulatory standards can be high, particularly for new entrants and smaller manufacturers.
The development of innovative and environmentally friendly products creates new opportunities in the market. As the healthcare industry moves towards sustainability, there is a growing demand for containers made from biodegradable materials or designed for easier recycling. This shift presents a significant opportunity for manufacturers to differentiate their products and tap into new market segments.
The rapid expansion of the market into emerging markets, where increasing healthcare expenditures and infrastructure development are creating new demand for medical supplies, including blood collection containers. Additionally, the integration of technology such as barcode scanning and data analytics for better tracking and management of specimens can enhance the functionality of blood collection products, offering another avenue for growth.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
Attributes |
Details |
Report Title |
Single-use Containers for Human Venous Blood Specimen Collection Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017 -2022 |
Forecast Period |
2024–2032 |
Segmentation |
Product Type (Vacuum Tubes, Micro-Collection Tubes, Serum Separator Tubes, Plasma Separation Tubes, and Others), Material (Plastic, Glass, and Others), End-user (Hospitals, Diagnostic Laboratories, Blood Banks, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, MarketTrends, and Revenue Forecast |
Key Players Covered in the Report |
BD; Greiner Bio-One International GmbH; Terumo Corporation; Sarstedt AG & Co. KG; Thermo Fisher Scientific Inc.; Medtronic; Cardinal Health, Inc.; FL Medical srl; Narang Medical Limited; Improve Medical Instruments Co., Ltd.; Kangjian Medical Apparatus Co., Ltd.; Sekisui Medical Co., Ltd.; ELITechGroup; F.L. Medical S.r.l.; Gongdong Medical Technology Co., Ltd.; Nipro Medical Corporation; Sanli Medical & Health Service Co., Ltd.; CML Biotech (P) Ltd.; Weigao Group; and Zhejiang Gongdong Medical Technology Co., Ltd. |
Vacuum tubes hold a major share of the single-use containers for human venous blood specimen collection market. These tubes are designed with a pre-calibrated vacuum, which automatically draws a predetermined volume of blood directly from the patient’s vein into the tube. This feature not only minimizes the complexity of the procedure but also enhances the safety and efficiency of blood collection, reducing the potential for human error and contamination. The vacuum tubes have seen substantial growth due to their widespread use in various diagnostic tests, including blood chemistry analyses, serology, and monitoring of blood disorders.
The demand is driven by the increasing prevalence of chronic diseases, which necessitates regular blood testing, and the growing emphasis on rapid and accurate diagnostic practices. Vacuum tubes are available in several types, each coated with specific additives that either promote or prevent blood clotting, catering to different testing purposes. This versatility further bolsters their adoption in hospitals, clinics, and diagnostic laboratories, fueling the growth of the segment.
Micro-collection tubes segment is anticipated to expand at a robust growth rate during the projection period, as these tubes are particularly favored for blood collection in pediatric, geriatric, or severely ill patients where blood conservation is essential. These tubes are designed for collecting small volumes of blood, which is particularly important in scenarios where patients are either difficult to draw from or have limited blood to spare for multiple tests.
The design and functionality of micro-collection tubes minimize the discomfort and health risks associated with multiple punctures in such vulnerable patients. The growing focus on minimally invasive techniques in medical testing and the rising number of blood tests performed on neonates and elderly patients have significantly propelled the demand for micro-collection tubes.
Plastic segment dominates the single-use containers for human venous blood specimen collection market, due toits widespread use is primarily attributed to its cost-effectiveness, lightweight nature, and versatility in manufacturing. Plastic tubes are less fragile compared to their glass counterparts, reducing the risk of breakage and potential injury during handling and transport. This durability makes plastic an ideal choice for high-volume, routine blood collection, particularly in settings such as hospitals and blood donation camps where the handling and transportation of samples can be rigorous.
Additionally, plastic containers can be easily manufactured in various sizes and with specific additives or coatings, such as anticoagulants or gel separators, which are essential for different types of blood tests. The adaptability of plastic to these modifications supports a broad range of diagnostic applications, further driving the growth of the segment.
Glass segment is projected to grow at a significant growth rate during the forecast period. Glass containers are highly valued for their non-reactive properties, which make them ideal for blood samples that require storage or transport under stringent conditions. The inert nature of glass ensures that there is no interaction between the container and the blood sample, preserving the integrity and reliability of the sample for subsequent analysis.
This is particularly critical for certain biochemical analyses and genetic testing, where sample contamination can lead to inaccurate results. Furthermore, glass tubes are often preferred for their transparency, which facilitates easy visual inspection of the sample for any anomalies such as clotting or hemolysis.
Hospitals segment holds a major share of the single-use containers for human venous blood specimen collection market, due to the high volume of blood tests conducted in hospital settings, where rapid and accurate diagnosis is crucial for effective patient management and treatment. Hospitals typically require a wide variety of blood collection containers to accommodate the diverse range of tests performed, from routine screenings to complex diagnostic procedures.
The demand in hospitals is driven by the need for efficient, hygienic, and reliable collection methods that minimize the risk of contamination and ensure patient safety. Single-use containers are particularly valued in this setting for their convenience and effectiveness in preventing cross-contamination among patients, which is a critical concern in hospitals dealing with high patient throughput. Additionally, the ongoing advancements in healthcare infrastructure and the increasing investment in hospital facilities globally contribute to the growth of the segment.
Diagnostic laboratories segment is projected to experience significant growth in the market. These facilities specialize in the analysis of clinical specimens, including blood, to diagnose and monitor various health conditions. The reliance on accurate and timely test results makes the quality and integrity of blood specimens a top priority for diagnostic laboratories. Single-use containers are essential in these settings for ensuring that samples are collected and stored under optimal conditions to prevent any compromise in their quality.
The growth of the segment is fueled by the increasing outsourcing of diagnostic testing by hospitals and the rise in private laboratory chains, which have expanded access to diagnostic services for a broader population. Moreover, the trend toward personalized medicine and the growing emphasis on preventive healthcare have led to an increase in regular health screenings, further driving the demand for blood collection products in diagnostic laboratories.
The Asia Pacific dominates the single-use containers for human venous blood specimen collection market, driven by rapid economic growth, increasing healthcare expenditures, and a rising awareness of preventive healthcare. Countries such as China and India are leading this growth due to their large populations and increasing incidence of chronic diseases such as diabetes and cardiovascular conditions, which require regular blood monitoring. For instance,
According to the NIH, there were around 138.2 million people with diabetes living in the Western Pacific region in 2020 and 90% of these being type 2 diabetes mellitus. This number of cases is projected to rise to 201.8 million by 2035.
The expansion of healthcare infrastructure and government initiatives aimed at improving healthcare services contribute significantly to the demand for blood collection products. In Japan, an aging population has heightened the need for healthcare services, including diagnostic testing, thus propelling the market for single-use blood collection containers. Additionally, the region is witnessing a surge in the establishment of private diagnostic laboratories and blood banks, further boosting the market growth.
The market in North America is projected to rapidly grow during the forecast period, due to its advanced healthcare system, high healthcare spending, and strong presence of leading market players. The US leads the market in this region, supported by a robust healthcare infrastructure and a high prevalence of lifestyle-related diseases that necessitate frequent blood testing. The increasing focus on preventive healthcare and wellness in the US has led to a rise in routine health examinations, driving the demand for blood collection products.
Additionally, the region is characterized by stringent regulatory standards ensuring high-quality and safety of medical devices, which sustains the demand for premium single-use blood collection containers. The presence of a well-established network of hospitals and diagnostic laboratories in the region further supports the continuous demand for single-use blood specimen collection containers, fueling the growth of the market.
The Single-use Containers for Human Venous Blood Specimen Collection Market has been segmented on the basis of
Key players in the single-use containers for human venous blood specimen collection market are BD; Greiner Bio-One International GmbH; Terumo Corporation; Sarstedt AG & Co. KG; Thermo Fisher Scientific Inc.; Medtronic; Cardinal Health, Inc.; FL Medical srl; Narang Medical Limited; Improve Medical Instruments Co., Ltd.; Kangjian Medical Apparatus Co., Ltd.; Sekisui Medical Co., Ltd.; ELITechGroup; F.L. Medical S.r.l.; Gongdong Medical Technology Co., Ltd.; Nipro Medical Corporation; Sanli Medical & Health Service Co., Ltd.; CML Biotech (P) Ltd.; Weigao Group; and Zhejiang Gongdong Medical Technology Co., Ltd.
To maintain and enhance their market positions, leading companies in this sector employ a variety of strategies. Innovation and product development are pivotal, with companies continuously investing in research and development to introduce more efficient and safer products. For instance,
In December 2023, BD, one of the leading global medical technology companies, announced it has received 510(k) clearances from the U.S.FDA for a blood collection device that obtains blood samples from a fingerstick.